About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us
More Company News
Redx Pharma
H122 interim results
23 Jun 2022
Read More
Redx Pharma
Pan-RAF inhibitor to enter clinic
15 Jun 2022
Read More
Redx Pharma
Poster on RXC004 at ASCO 2022
30 May 2022
Read More
Redx Pharma
Result of accelerated book build
19 May 2022
Read More
Redx Pharma
Launch of placing via accelerated book build
18 May 2022
Read More
Redx Pharma
RXC004 data to be presented at ASCO
27 Apr 2022
Read More
Redx Pharma
RXC004 preclinical data presented at AACR
08 Apr 2022
Read More
Redx Pharma
Collaboration with Garvan Institute of Medical Research
05 Apr 2022
Read More
Redx Pharma
RXC008 nominated as GI ROCK clinical development candidate
30 Mar 2022
Read More
Redx Pharma
Encouraging RXC007 Phase I safety data
10 Mar 2022
Read More
1
2
3
4
Return to Redx Pharma
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us